CN Patent
CN101163479B — 固体药物剂型
Assigned to AbbVie Inc · Expires 2011-12-07 · 14y expired
What this patent protects
本发明提供了一种药物制剂,更具体的是包含HIV蛋白酶抑制剂的药物制剂。
USPTO Abstract
本发明提供了一种药物制剂,更具体的是包含HIV蛋白酶抑制剂的药物制剂。
Drugs covered by this patent
- Myrbetriq (MIRABEGRON) · Apgdi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.